Cormedix(DE:19KA)
€4.16+0.14 (+3.58%)
DE:19KA
Cormedix earnings date
€4.16
At close:+0.14 (+3.58%)
Cormedix (19KA) Q2 2026 Earnings Report
2 Followers
DE:19KA Q2 2026 EPS Results
- Actual EPS
- EUR 0.26
- Consensus EPS
- EUR 0.22
- Beat/Miss
- Beat by +EUR 0.05
- One Year Ago EPS
- EUR 0.26
DE:19KA Q2 2026 Revenue Results
- Actual Revenue
- EUR 92.92M
- Expected Revenue
- EUR 87.55M
- Beat/Miss
- Beat by +EUR 5.37M
- YoY Revenue Growth
- +156.52%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- Before Open
- Conference Call
- Thursday, August 13, 2026
DE:19KA Upcoming Earnings
Cormedix's next earnings date is estimated for March 30, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:19KA Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:19KA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2027 | 2026 (Q4) | -0.14- | 0.15 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.11-0.17 | 1.15 | -115.08% (-1.32) | |
| Aug 13, 2026 | 2026 (Q2) | 0.220.26 | 0.26 | 0.00% (+0.00) | |
| May 14, 2026 | 2026 (Q1) | 0.310.39 | 0.27 | 43.33% (+0.12) | |
| Mar 05, 2026 | 2025 (Q4) | 0.740.15 | 0.2 | -27.27% (-0.05) | |
| Nov 12, 2025 | 2025 (Q3) | 0.581.15 | -0.05 | 2620.00% (+1.19) | |
| Aug 07, 2025 | 2025 (Q2) | 0.170.26 | -0.23 | 216.00% (+0.49) | |
| May 06, 2025 | 2025 (Q1) | 0.240.27 | -0.23 | 220.00% (+0.50) | |
| Mar 25, 2025 | 2024 (Q4) | 0.120.20 | -0.24 | 184.62% (+0.44) | |
| Oct 30, 2024 | 2024 (Q3) | -0.11-0.05 | -0.15 | 70.59% (+0.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

